Myomo (MYO) Gross Margin (2016 - 2025)
Myomo's (MYO) quarterly Gross Margin came in at 63.84% in Q3 2025, down 1159.0% on a YoY basis from 6.03% in Q3 2024, and up 1.82% quarter-over-quarter from 62.7% in Q2 2025.
Powered by 
Analysis
Myomo (MYO) Gross Margin (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Gross Margin for 10 consecutive years, with 63.84% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Gross Margin fell 1159.0% year-over-year to 63.84%; the trailing twelve-month figure through Sep 2025 stood at 66.56% (down 347.0% YoY), and the FY2024 full-year result was 71.23%, up 272.0% from the prior year.
- Gross Margin rose to 63.84% in Q3 2025 per MYO's latest filing, from 62.7% in the prior quarter.
- Across five years, Gross Margin topped out at 77.45% in Q4 2021 and bottomed at 61.24% in Q1 2024.
- Historically, Gross Margin has averaged 68.69% across 5 years, with a median of 67.23% in 2025.
- The sharpest annual moves came in 2021 and 2022: Gross Margin surged 1974 bps in 2021, then sank 1243 bps in 2022.
- Over 5 years, Gross Margin stood at 77.45% in 2021, then fell by 16 bps to 65.02% in 2022, then advanced by 0 bps to 65.28% in 2023, then increased by 9 bps to 71.39% in 2024, then declined by 11 bps to 63.84% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 63.84%, 62.7%, and 67.23% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 45.84% |
| 10 | Myomo | 56.51 Mn | 37.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 63.84% |
| Jun 30, 2025 | 62.70% |
| Mar 31, 2025 | 67.23% |
| Dec 31, 2024 | 71.39% |
| Sep 30, 2024 | 75.43% |
| Jun 30, 2024 | 70.81% |
| Mar 31, 2024 | 61.24% |
| Dec 31, 2023 | 65.28% |
| Sep 30, 2023 | 68.68% |
| Jun 30, 2023 | 71.85% |
| Mar 31, 2023 | 66.95% |
| Dec 31, 2022 | 65.02% |
| Sep 30, 2022 | 66.45% |
| Jun 30, 2022 | 65.29% |
| Mar 31, 2022 | 66.63% |
| Dec 31, 2021 | 77.45% |
| Sep 30, 2021 | 74.68% |
| Jun 30, 2021 | 70.96% |
| Mar 31, 2021 | 73.33% |
| Dec 31, 2020 | 73.42% |